Northern Trust
ELOX

Northern Trust’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Northern Trust’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,092
Closed -$21K – 4746
2022
Q3 		$21K Hold
3,092
– – ﹤0.01% 4538
2022
Q2 		$33K Hold
3,092
– – ﹤0.01% 4532
2022
Q1 		$69K Sell
3,092
-17
-0.5% -$335 ﹤0.01% 4453
2021
Q4 		$88K Hold
3,109
– – ﹤0.01% 4463
2021
Q3 		$202K Sell
3,109
-313
-9% -$19.3K ﹤0.01% 4177
2021
Q2 		$273K Sell
3,422
-3,883
-53% -$324K ﹤0.01% 3998
2021
Q1 		$970K Sell
7,305
-747
-9% -$114K ﹤0.01% 3594
2020
Q4 		$1.28M Sell
8,052
-69
-0.8% -$8.43K ﹤0.01% 3413
2020
Q3 		$854K Sell
8,121
-416
-5% -$49.8K ﹤0.01% 3454
2020
Q2 		$1.03M Buy
8,537
+639
+8% +$72.3K ﹤0.01% 3343
2020
Q1 		$619K Buy
7,898
+680
+9% +$111K ﹤0.01% 3392
2019
Q4 		$2.13M Sell
7,218
-80
-1% -$16.1K ﹤0.01% 3100
2019
Q3 		$1.32M Sell
7,298
-207
-3% -$58.9K ﹤0.01% 3298
2019
Q2 		$2.99M Buy
7,505
+328
+5% +$138K ﹤0.01% 2843
2019
Q1 		$3.35M Buy
7,177
+139
+2% +$67.5K ﹤0.01% 2787
2018
Q4 		$3.38M Sell
7,038
-12
-0.2% -$6.62K ﹤0.01% 2745
2018
Q3 		$4.8M Buy
7,050
+5,148
+271% +$3.3M ﹤0.01% 2706
2018
Q2 		$1.3M Buy
+1,902
New +$1.23M ﹤0.01% 3392

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust's ELOX Position: Q4 2022 in Review

Northern Trust sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 3,092 shares — an estimated $21K sold.

Northern Trust first reported a position in ELOX in Q2 2018 and held it in 18 quarters. The position peaked at $4.8M in Q3 2018. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Northern Trust reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Northern Trust sold 3,092 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $21K.
  • Northern Trust first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
  • Northern Trust's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $4.8M in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.